We're keeping up with you

Welcome to the first of FiercePharma Manufacturing's two issues this week! Your email in-box on Thursday will contain issue #2.

George Miller, Fiercepharmamanufacuring Editor

We're upping the frequency for two reasons. First is the need to keep pace with developments in pharmaceutical and bioprocessing operations. In spite of the poor economy, we've seen the industry gain momentum since we launched last summer. Business collaborations, facility openings, manufacturing practice updates, and supply chain advances are coming at us too quickly and at too great a volume to warrant just once-a-week coverage.

Second, our subscriber rolls have grown beyond our expectations. Although that's not by itself an indicator for a frequency increase, it's been accompanied by a swell of interest and participation from manufacturing service providers, product vendors, and industry groups--all of whom have something they want to say to you.

So enjoy this first of two issues this week. And know that you'll get another briefing as the week comes to a close.


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.